| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Restricted Stock Units | 1.32M | May 21, 2025 | Direct | ||
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Stock Option | 481K | Aug 31, 2024 | Direct | ||
| AEON Biopharma, Inc. | Exec VP, CLO & Corp Secretary | Class A Common Stock | 262K | Aug 31, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | May 21, 2025 | 1 | $0 | 4 | May 23, 2025 | Exec VP, CLO & Corp Secretary |
| AEON | AEON Biopharma, Inc. | Aug 31, 2024 | 2 | $0 | 4 | Sep 4, 2024 | EXEC VP, CLO & CORP SECRETARY |
| AEON | AEON Biopharma, Inc. | Mar 19, 2024 | 1 | $0 | 4 | Mar 21, 2024 | EXEC VP, CLO & CORP SECRETARY |
| AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 4 | $0 | 4 | Jul 24, 2023 | CLO and Corporate Secretary |
| AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Exec VP, CLO & Corp Secretary |